Jim, biowa, Dave..... the suggestions have been solid ones. BPUR...... picked by all three of you esteemed traders, but, but, but.......
>> BPUR could really rocket in a market like this (DAK) <<
..... while I agree, that's not in line with the spirit and intent of "2000". The portfolio was designed to protect one's butt, while still allowing the leverage for upward punch (it's already up about 9%, if you fudge for a KDUS quote). Burn 10M/qtr, current cash is probably about $1.30/share. Nope, nope, nope. Might add it to my PP, however.
- g -
Leaning to ARDM or, now that it's come back a bit, NPSP, among the suggestions. Gonna chew on the ideas.
Globex NSDQ100 is currently down 37.5. Could be worse. Could be a lot better. I've seen some encouraging signs, however, that some of the dot com money is looking for undervalued biotechs. |
